Capstone Triton Financial Group LLC Has $968,000 Stock Position in The Clorox Company (NYSE:CLX)

Capstone Triton Financial Group LLC lessened its stake in shares of The Clorox Company (NYSE:CLX) by 1.7% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 5,945 shares of the company’s stock after selling 103 shares during the period. Capstone Triton Financial Group LLC’s holdings in Clorox were worth $968,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Insight Folios Inc boosted its position in Clorox by 3.0% during the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares during the period. Fiduciary Group LLC increased its holdings in shares of Clorox by 0.4% during the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after purchasing an additional 72 shares during the period. GHP Investment Advisors Inc. grew its position in Clorox by 2.0% during the second quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after buying an additional 72 shares in the last quarter. SPC Financial Inc. boosted its stake in Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after buying an additional 75 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV increased its holdings in Clorox by 17.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after buying an additional 75 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.51% of the stock is currently owned by company insiders.

Clorox Stock Down 0.3 %

Shares of NYSE:CLX traded down $0.43 during midday trading on Wednesday, hitting $156.40. The stock had a trading volume of 248,511 shares, compared to its average volume of 1,218,376. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The business’s 50-day simple moving average is $161.02 and its 200-day simple moving average is $145.82. The company has a market cap of $19.42 billion, a P/E ratio of 81.25, a PEG ratio of 3.19 and a beta of 0.41. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. On average, sell-side analysts forecast that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.12%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is 252.85%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Wells Fargo & Company dropped their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Barclays lifted their price target on shares of Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a research report on Friday, October 11th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Finally, JPMorgan Chase & Co. upped their price objective on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Six equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $150.14.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.